ClinicalTrials.gg
RecruitingNCT06259643chair-soccerUpdated Feb 14, 2024

Effects of Power Wheelchair Soccer for Individuals Presenting With Physical Impairments

An interventional study of Power wheelchair soccer in Neuromuscular Diseases and Cerebral Palsy, sponsored by Université Catholique de Louvain. Recruiting at 1 site in Belgium. Open to participants aged 12 Years to 50 Years. Per ClinicalTrials.gov, last updated 2024-02-14.

Sponsored by Université Catholique de Louvain · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 5 months ago, but the record still lists the study as recruiting.
  • Started Nov 2023; still recruiting 3 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
12 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 23 studies in Neuromuscular Diseases with a site in Belgium — 7 open to participants now, 11 under way, 3 of them phase 3. Neuromuscular Diseases · Belgium.

Planned enrollment
18th of 20
20 · median 77
Started
2023
with 3 others
No phase
9 of 23
4 open now
Primary completion
2024-06
later than 1 of 10 live
Registered
18th of 23
by date

Among the 23 studies in Neuromuscular Diseases with a site in Belgium, this one is the 18th largest by planned enrollment of the 20 interventional ones that give a count, is one of 4 that started in 2023, is one of 9 with no phase, reaches primary completion later than 1 of the 10 other live ones, and was the 18th registered.

Neuromuscular Diseases

361 studies on the registry are indexed under Neuromuscular Diseases; 96 are open to participants now.

Browse Neuromuscular Diseases studies →

Open to participants now

7 of the 23 studies in Neuromuscular Diseases with a site in Belgium are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →

Who these studies take

Of the 69 Neuromuscular Diseases studies recruiting now, 39 (57%) set no upper age limit and 22 (32%) stop at 75 or younger; 35 take children under 18; 16 take healthy volunteers.

This study: 12 Years to 50 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Neuromuscular Diseases with a site in Belgium, or all of them as a file.
02

Study summary

This study is a prospective interventional study. It will be conducted at a single center with participants who have neuromotor impairments. The primary objective is to assess and measure the clinical and psychosocial effects of a season of power wheelchair soccer among its participants presenting with severe motor impairments due to neuromuscular lesion.

A maximum of twenty participants will be recruited and included in the same group. Data collection will be performed before, during, and after the wheelchair soccer season. The study will span the entire season, starting in November 2023 and ending in June 2024.

Clinical and psychosocial assessments will be conducted every 3 months. Each assessment session will last 2 hours per participant. Before and after the wheelchair soccer season matches, we will evaluate parameters related to the physical load of the sport. These evaluations will last 10 minutes per participant.

03

Conditions studied

  • Neuromuscular Diseases
  • Cerebral Palsy
04

Who can participate

Ages eligible
12 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being a male or female between the ages of 12 and 50.
  • Presenting with severe motor impairments due to neuromotor and/or musculoskeletal impairment.
  • Using a power wheelchair in everyday life.
  • Being part of a power wheelchair soccer team.
  • Committing to participating in the 2023-2024 season of their sport within the team.

Exclusion criteria

Exclusion Criteria:

  • Practicing another adaptive sport outside of power wheelchair soccer in a regular way (once a week or more).
  • Occasionally practicing power wheelchair soccer (twice a month or less).
  • Presenting with severe cognitive impairments affecting understanding of instructions on how to answer questionnaires and undertake tests.
  • Presenting with towards the practice of an adaptive sport such as power wheelchair soccer.

    • Participating in another study at baseline.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Power wheelchair soccer

    soccer game performed with a wheelchair

    Other: Power wheelchair soccer

Interventions

  • OtherPower wheelchair soccer

    Participants will practice power wheelchair soccer during the course of the power wheelchair soccer season (starting in November 2023 and ending in June 2024). Sessions are given once a week, by a coach with experience in this adaptive sport.

06

What researchers measure

Primary outcomes

  1. Balance

    Balance will be measured using the Trunk control measurement scale. Scores range from 0 to 58, where a higher score displays better trunk control.

    Time frame: Throughout the entire study (an average of 8 months)

  2. Balance

    Balance will be measured using the Level of sitting scale. Levels range from 1 to 8, where a higher score demonstrates better sitting balance.

    Time frame: Throughout the entire study (an average of 8 months)

  3. Balance

    Balance will be measured using the function section of the Seated Postural Control measure. Scores range from 12 to 48, where a higher score is attributed to individuals with better postural control.

    Time frame: Throughout the entire study (an average of 8 months)

  4. Sensorimotor impairment

    Sensorimotor impairment will be measured by the Fugl-Meyer assessment.

    Time frame: Throughout the entire study (an average of 8 months)

  5. Hyperactivity of the muscles

    Hyperactivity of the muscles will be measured using the Australian Spasticity Assessment scale of the upper-limb main muscle groups. Scores per muscle groups range from 0 to 4, where a higher score represents greater spasticity and more hyperactivity in the muscle group.

    Time frame: Throughout the entire study (an average of 8 months)

  6. Hyperactivity of the muscles

    Hyperactivity of the muscles will be measured using the Penn Spasm Frequency Scale. Scores range from 0 to 4, where a higher score represents more frequent spasms and hyperactivity of the muscles.

    Time frame: Throughout the entire study (an average of 8 months)

  7. Pain

    Pain perceived by the participants in their daily life will be measured using the PROMIS pain-pediatric Short Form V2 questionnaire. Scores range from 8 to 40, where a higher score displays more pain in everyday life.

    Time frame: Throughout the entire study (an average of 8 months)

  8. Quality of life

    Quality of life will be assessed using the KIDSCREEN 27 questionnaire. Scores range from 10 and 50, where 50 represents a very high health-related quality of life.

    Time frame: Throughout the entire study (an average of 8 months)

  9. Skills to manage and move power wheelchair

    Skills to manage and move power wheelchair will be assessed by the Wheelchair Skills Test Questionnaire version 4.2. Scores range from 0 to 100%, where a greater percentage represents better skills.

    Time frame: Throughout the entire study (an average of 8 months)

  10. Social participation

    Social participation will be assessed using the Questionnaire of young people's participation.Scores range from 0 to 239, where a higher score displays greater social participation.

    Time frame: Throughout the entire study (an average of 8 months)

  11. Autonomy during activities of daily life

    Autonomy during activities of daily life will be assessed using the Impact on participation and autonomy questionnaire. A participation score (range: 30-155) and a problem score (0-16) are produced by summing items in each scale. For both, a higher score represent poorer autonomy and more severe difficulty.

    Time frame: Throughout the entire study (an average of 8 months)

  12. Strength of the upper-limbs

    Strength of the main muscle groups of the upper-limb will be measured using a Microfet 2 dynamometer.

    Time frame: Throughout the entire study (an average of 8 months)

  13. Passive range of motion the upper-limbs

    Passive range of motion of the upper-limbs will be measured using a goniometer.

    Time frame: Throughout the entire study (an average of 8 months)

Secondary outcomes

  1. Body temperature

    Body temperature will be evaluated using a tympanic thermometer.

    Time frame: Throughout the entire study (an average of 8 months)

  2. Blood oxygen saturation

    Blood oxygen saturation will be evaluated using a pulse oximeter.

    Time frame: Throughout the entire study (an average of 8 months)

  3. Heart beat rate

    Heart beat rate will be evaluated using a heart rate monitor.

    Time frame: Throughout the entire study (an average of 8 months)

  4. Blood pressure

    Blood pressure will be evaluated on the left upper-arm with a tensiometer. Both systolic and diastolic pressure will be recorded.

    Time frame: Throughout the entire study (an average of 8 months)

Other outcomes

  1. Satisfaction with the power wheelchair soccer practices

    Satisfaction with the power wheelchair soccer practices will be evaluated on a 10 point Likert-scale. A higher score displays greater satisfaction with the practices.

    Time frame: Throughout the entire study (an average of 8 months)

  2. Demographic variables

    Participants' age, sex, origin of physical impairment, motor impairment severity, hours of physical therapy per week, as well as motor impairment severity, will be collected.

    Time frame: Throughout the entire study (an average of 8 months)

07

Study locations

1 of 1 sites recruiting
  • Neuromusculoskeletal Lab
    Brussels, 1200, Belgium
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2023 (actual). Primary completion is estimated for Jun 2024, 7 months after the start.

Of 75 non-industry interventional studies with no phase under Neuromuscular Diseases, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 47. This study's planned 7 months is below that.

Counting every sponsor, half of 84 studies reached it within 25 months; a quarter within 12 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 23, 2024
First posted
Feb 14, 2024
StartActual
Nov 1, 2023
Primary completionEst.
Jun 15, 2024
CompletionEst.
Jun 15, 2024
Last update
Feb 14, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 14, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06259643
Responsible party
Sponsor
First posted
Feb 14, 2024
Start date
Nov 1, 2023
Primary completion
Jun 15, 2024 (estimated)
Completion
Jun 15, 2024 (estimated)
Last update
Feb 14, 2024

Study contacts

Louise Declerck, PT
Contact
louise.declerck@uclouvain.be
0476480314 ext. +32

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion